Security key
G52441105
KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (KMTS)
CUSIP: G52441105
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 48,395,709
- Total 13F value
- $1,149,884,732
- Share change
- +1,018,610
- SEC-reported price per share
- $23.76
- Number of holders
- 79
- Value change
- +$50,205,342
- Number of buys
- 55
- Number of sells
- 27
- Shares outstanding
- 58,516,314
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
79
Top holders
10
KMTS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
KESTRA MEDICAL TECHNOLOGIES, LTD. SEC filings
KESTRA MEDICAL TECHNOLOGIES, LTD. company facts
Broader feeds
Reporting periods
Holder history for CUSIP G52441105
Recent filing periods:
Ownership snapshot
Top reported holders of KMTS - KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
BAIN CAPITAL INVESTORS LLC
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
13F
3/4/5
Lead comparable stake: 10%
13D/G row: FMR LLC
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
10%
Jeffrey Lawrence Schwartz
46%
Mary Kay Ladone
0.04%
Conor Hanley
0.02%
Elizabeth Kwo
0.02%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13D/G
13F
Company
|
10%
|
$96,158,179
5,225,988 shares
|
+$38,804,570 | 30 Sep 2025 |
| Jeffrey Lawrence Schwartz |
3/4/5
Director, 10%+ Owner
|
46%
|
$429,508,829
27,030,134 shares
|
— | 04 Sep 2025 |
| Mary Kay Ladone |
3/4/5
Director
|
0.04%
|
$379,818
23,903 shares
|
— | 04 Sep 2025 |
| Conor Hanley |
3/4/5
Director
|
0.02%
|
$208,476
13,120 shares
|
— | 04 Sep 2025 |
| Elizabeth Kwo |
3/4/5
Director
|
0.02%
|
$173,344
10,909 shares
|
— | 04 Sep 2025 |
| BAIN CAPITAL INVESTORS LLC |
13F
3/4/5
Company · 10%+ Owner
|
46%
|
$447,978,751
27,019,225 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
79
Shares
48,395,709
Rows available
79
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q1 2026 Across Filers
Q1 2026 holders
101
Q3 2025 holders
79
Holder diff
-22
| Investor | Q1 2026 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q1 2026 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend